We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$1.3B
Cap. Flow
+$1.27B
Cap. Flow %
62.75%
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,161
Increased
164
Reduced
123
Closed
87

Sector Composition

Rank Sector Weight
1 Financials 6.93%
2 Consumer Discretionary 6.9%
3 Healthcare 6.22%
4 Industrials 4.3%
5 Technology 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGEN
2151
Tecogen Inc
TGEN
$118M
$73K ﹤0.01%
+22,797
New +$74K
DAG
2152
DELISTED
DB Agriculture Double Long ETN due April 1, 2038
DAG
$73K ﹤0.01%
+24,079
New +$77.9K
CASI
2153
DELISTED
CASI Pharmaceuticals
CASI
$72K ﹤0.01%
+4,079
New +$47.6K
GROW icon
2154
US Global Investors
GROW
$38.3M
$72K ﹤0.01%
+33,656
New +$50K
NCV
2155
Virtus Convertible & Income Fund
NCV
$392M
$72K ﹤0.01%
+2,520
New +$71K
SFUN
2156
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$72K ﹤0.01%
+355
New +$62.8K
LSCC icon
2157
Lattice Semiconductor
LSCC
$18.2B
$71K ﹤0.01%
+13,541
New +$82.4K
MN
2158
DELISTED
MANNING & NAPIER, INC.
MN
$71K ﹤0.01%
+17,911
New +$68.5K
SVA
2159
DELISTED
Sinovac Biotech, Ltd
SVA
$71K ﹤0.01%
+10,119
New +$69.1K
VKTX icon
2160
Viking Therapeutics
VKTX
$4.01B
$70K ﹤0.01%
+36,588
New +$41.6K
ADYX
2161
DELISTED
Adynxx Inc
ADYX
$70K ﹤0.01%
+3,206
New +$66.3K
DXTR
2162
DELISTED
Dextera Surgical Inc.
DXTR
$70K ﹤0.01%
+255,494
New +$73.5K
FBIO icon
2163
Fortress Biotech
FBIO
$88M
$69K ﹤0.01%
+1,044
New +$70.4K
CMRX
2164
DELISTED
Chimerix, Inc.
CMRX
$69K ﹤0.01%
+13,228
New +$65.1K
TLGT
2165
DELISTED
Teligent, Inc
TLGT
$68K ﹤0.01%
+1,018
New +$74.6K
TGA
2166
DELISTED
Transglobe Energy Corp
TGA
$67K ﹤0.01%
+48,703
New +$62.1K
ARLZ
2167
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$67K ﹤0.01%
+29,468
New +$39.4K
LRMR icon
2168
Larimar Therapeutics
LRMR
$437M
$66K ﹤0.01%
+1,572
New +$65.4K
MRNS
2169
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$66K ﹤0.01%
+2,824
New +$31.7K
DTEA
2170
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$66K ﹤0.01%
+15,559
New +$81.4K
OMNT
2171
DELISTED
Ominto, Inc. Common Stock
OMNT
$66K ﹤0.01%
+14,719
New +$85.4K
TEUM
2172
DELISTED
Pareteum Corporation
TEUM
$66K ﹤0.01%
+43,580
New +$43.4K
DHF
2173
BNY Mellon High Yield Strategies Fund
DHF
$173M
$65K ﹤0.01%
+18,362
New +$64.4K
OBE
2174
Obsidian Energy
OBE
$711M
$65K ﹤0.01%
+8,861
New +$65.6K
WIT icon
2175
Wipro
WIT
$19.5B
$65K ﹤0.01%
+30,672
New +$67.2K

Similar funds

Virtu Financial's Q3 2017 Portfolio in Review

As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,161 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 6.9% of assets, up from 5.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.

  • Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
  • Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
  • Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
  • Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
  • Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
  • Virtu Financial opened 2,161 new positions and closed 87 in Q3 2017.
  • Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.

Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.